聚合物纳米配方旨在重编程癌症代谢,具有高特异性来抑制瘤生长
Yu Xia1, Ming-Kang Zhang1, Jing-Jie Ye1
1Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, P.R. China. fengjun@whu.edu.cn.
Biomaterials science
|September 2, 2024
概括
这项研究开发了一种新型的纳米纤维,专门针对和重编程癌细胞代谢,减少葡萄糖摄入量并增强癌细胞死亡. 这种方法有效地抑制了小鼠的瘤生长,对正常细胞的伤害最小.
科学领域:
- 生物医学工程 生物医学工程
- 癌症生物学 癌症生物学
- 纳米技术 纳米技术
背景情况:
- 癌细胞表现出可用于向治疗的代谢漏洞.
- 癌症中的细胞可塑性和代谢异质性对选择性消除构成挑战.
- 开发特定的代谢干预措施需要克服这些复杂性.
研究的目的:
- 设计一种纳米配方,用于针对性地重编程癌细胞代谢.
- 通过集成的细胞外和细胞内干预来实现选择性癌细胞消除.
- 在体内评估纳米配方的治疗疗效和生物安全性.
主要方法:
- 用双重药物装载的巨细胞膜涂层聚合物纳米纤维的制造.
- 研究纳米配方对癌细胞葡萄糖吸收和代谢的影响.
- 评估对细胞酸盐摄入量,活性氧物种 (ROS) 生产和NADPH水平的影响.
- 在携带瘤的小鼠中评估瘤生长抑制和巨细胞表型调节.
主要成果:
- 该纳米配方选择性地向癌细胞,减少葡萄糖摄入量并重定向细胞内葡萄糖代谢.
- 它抑制酸盐的吸收,诱导过氧化 (H2O2) 的产生,并降低NADPH的调节,增强氧化还原损害.
- 在体内观察到显著的瘤生长抑制和促进瘤巨细胞转化为抑制瘤的表型.
- 纳米配方对癌细胞具有很高的选择性,对正常细胞的毒性最小.
结论:
- 开发的纳米配方有效地为选择性毒性重新编程癌症代谢.
- 这种方法通过利用代谢漏洞,为癌症治疗提供了一个有希望的策略.
- 在临床前模型中,纳米配方表现出有利的生物安全性和治疗潜力.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493


